person · Reporting owner
Glibert Christian Michael
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ENvue Medical, Inc.
Report date June 22, 2026 · Filed June 22, 2026
Section 16 reporting ended · disclosed 2026-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-22 transaction · row 1
1 source rowRow 1 · 2026-06-22 · Sale · Disposed 210,000 · Balance 0 F1: Shares were sold in multiple transactions ranging from $.6756 to $.722. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were sold in multiple transactions ranging from $.6756 to $.722.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2026 Filed Jun 22, 2026 17:43 UTC | ENvue Medical, Inc. $FEED · Entity 8385 | SaleCommon Stock | 210,000 | $0.69 | $144,480.00 |
DisclosureSEC source: 0002111050-26-000007 · primary_doc.xml · nonDerivative · entry 1 Glibert Christian Michael · CIK 0002111050 · No longer subject to section 1 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Shares were sold in multiple transactions ranging from $.6756 to $.722. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 21:10 UTC | ENvue Medical, Inc. FEED · Entity 8385 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0002111050-26-000005 · primary_doc.xml · nonDerivative · entry 1 Glibert Christian Michael · CIK 0002111050 · No longer a 10% holder 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,000 F1 · kind: The Reporting Person's percentage of beneficial ownership dropped below 10 percent due to dilution resulting from the Issuer's issuance of shares in connection with a merger, as reported in the Issuer's Form 10-K filed on April 15, 2026. No shares were disposed of or acquired by the Reporting Person. Read SEC document |
| January 14, 2026 Filed Feb 11, 2026 23:52 UTC | ENvue Medical, Inc. FEED · Entity 8385 | PurchaseCommon Stock, par value $0.001 per share | 240,000 | $2.67 | $640,800.00 |
DisclosureSEC source: 0002111050-26-000002 · primary_doc.xml · nonDerivative · entry 1 Glibert Christian Michael · CIK 0002111050 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: The percentage of ownership is based on 1,088,192 shares of Common Stock outstanding as of the Issuer's most recent filings in February 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.